Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Gain-of-function and loss-of-function GABRB3 variants lead to distinct clinical phenotypes in patients with developmental and epileptic encephalopathies

Research output: Contribution to journalJournal articlepeer-review

  1. cyCombine allows for robust integration of single-cell cytometry datasets within and across technologies

    Research output: Contribution to journalJournal articlepeer-review

  2. Serum metabolome associated with severity of acute traumatic brain injury

    Research output: Contribution to journalJournal articlepeer-review

  3. Structural basis for PoxtA-mediated resistance to phenicol and oxazolidinone antibiotics

    Research output: Contribution to journalJournal articlepeer-review

  4. A nationwide questionnaire study of post-acute symptoms and health problems after SARS-CoV-2 infection in Denmark

    Research output: Contribution to journalJournal articlepeer-review

  1. Use of inhaled antibiotics among Danish patients with cystic fibrosis

    Research output: Contribution to journalJournal articlepeer-review

  2. Genetikken fremmer individualiseret behandling af epilepsi

    Research output: Contribution to journalReviewpeer-review

  3. Trisomy 20p/monosomy 18p associated with congenital bilateral perisylvian syndrome

    Research output: Contribution to journalJournal articlepeer-review

  4. SLC7A3: In Silico Prediction of a Potential New Cause of Childhood Epilepsy

    Research output: Contribution to journalJournal articlepeer-review

  • Nathan L Absalom
  • Vivian W Y Liao
  • Katrine M H Johannesen
  • Elena Gardella
  • Julia Jacobs
  • Gaetan Lesca
  • Zeynep Gokce-Samar
  • Alexis Arzimanoglou
  • Shimriet Zeidler
  • Pasquale Striano
  • Pierre Meyer
  • Ira Benkel-Herrenbrueck
  • Inger-Lise Mero
  • Jutta Rummel
  • Mary Chebib
  • Rikke S Møller
  • Philip K Ahring
View graph of relations

Many patients with developmental and epileptic encephalopathies present with variants in genes coding for GABAA receptors. These variants are presumed to cause loss-of-function receptors leading to reduced neuronal GABAergic activity. Yet, patients with GABAA receptor variants have diverse clinical phenotypes and many are refractory to treatment despite the availability of drugs that enhance GABAergic activity. Here we show that 44 pathogenic GABRB3 missense variants segregate into gain-of-function and loss-of-function groups and respective patients display distinct clinical phenotypes. The gain-of-function cohort (n = 27 patients) presented with a younger age of seizure onset, higher risk of severe intellectual disability, focal seizures at onset, hypotonia, and lower likelihood of seizure freedom in response to treatment. Febrile seizures at onset are exclusive to the loss-of-function cohort (n = 47 patients). Overall, patients with GABRB3 variants that increase GABAergic activity have more severe developmental and epileptic encephalopathies. This paradoxical finding challenges our current understanding of the GABAergic system in epilepsy and how patients should be treated.

Original languageEnglish
Article number1822
JournalNature Communications
Volume13
Issue number1
Pages (from-to)1822
ISSN2041-1722
DOIs
Publication statusPublished - 5 Apr 2022

Bibliographical note

© 2022. The Author(s).

    Research areas

  • Epilepsy/genetics, Gain of Function Mutation, Humans, Phenotype, Receptors, GABA-A/genetics, Seizures

ID: 76235240